AptarGroup, Inc.
ATRHealthcareNASDAQMedical Instruments & Supplies
Scan Results
Daily timeframePart of the healthcare sector, AptarGroup, Inc. (ATR) is listed under Medical Instruments & Supplies. The company carries a $8.46B market cap, placing it firmly in the mid-cap category. The company operates through three segments: Pharma, Beauty, and Closures.
Market Cap
$8.46B
Beta
0.39
P/E (TTM)
23.10
P/E (Fwd)
21.21
EPS (TTM)
$5.74
EPS (Fwd)
$6.25
ROE
14.8%
ROA
6.6%
Cash
$229.5M
Total Debt
$1.44B
Free CF
$253.0M
52W Change
-15.2%
Annual Financials
Cash vs Debt
The company holds $229.5M in cash, though total debt stands at $1.44B. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. The company generates $253.0M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. Return on equity stands at 14.8%, which is decent for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. An ROA of 6.6% suggests reasonable efficiency in deploying the company's asset base. Revenue has been uneven over recent years, ranging from $3.32B to $3.78B.
The relatively low beta of 0.39 suggests ATR is a less volatile holding compared to the broader index. The debt-to-cash ratio suggests meaningful leverage on the balance sheet, a factor worth monitoring if credit conditions tighten. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing ATR.